Skip to content

Neurogene Inc.

NGNE

CIK 0001404644

← back to feed
Revenue (TTM)
$925K
−100.0% YoY Q1 May 2026
Net Income (TTM)
−$96.55M
−20.2% YoY Q1 May 2026
EPS Diluted (TTM)
−$4.51
+0.9% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-11,799.7%
Q1 May 2026
Net Margin
-10,437.8%
Q1 May 2026
Free Cash Flow (TTM)
−$83.25M
Q1 May 2026
Cash
$124.16M
Q1 May 2026
Total Debt
—
Q1 May 2026
Shares Outstanding
15.8M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings